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Abstract
Background: Ganglioneuromatous polyposis (GP) is a very rare disorder which may be associated with other
clinical manifestations and syndromes, such as Cowden syndrome, multiple endocrine neoplasia (MEN) type II and
neurofibromatosis (NF) 1. The risk for malignant transformation of ganglioneuromas is unknown, and the
combination of GP with colon cancer has been only very seldom reported.
Methods and results: We report the case of a 60-year old male patient with adenocarcinoma, adenomas and
lipomas of the colon and multiple gastroduodenal lesions combined with generalised lipomatosis and
macrocephaly. Based on the initial endoscopic and histological findings, a (restorative) proctocolectomy was
recommended but declined by the patient. Instead, a colectomy was performed. The histological examination
revealed an unforeseen GP in addition to the colon cancer. Extensive molecular diagnostics allowed for the
differential diagnosis of the causes of the clinical manifestations, and the clinical suspicion of Cowden syndrome
could not be confirmed using Sanger Sequencing and MLPA for the analysis of PTEN. Finally, a pathogenic germline
mutation in PTEN (heterozygous stop mutation in exon 2: NM_000314 (PTEN):c.138C > A; p.Tyr46*) could be
detected by next-generation sequencing (NGS), confirming an unusual presentation of Cowden syndrome with GP.
Conclusions: Cowden syndrome should be considered in cases of GP with extracolonic manifestation and verified
by combined clinical and molecular diagnostics. Because GP may represent a premalignant condition, a surgical-
oncological prophylactic procedure should be considered. Based on our experience, we recommend early
implementation of Panel NGS rather than classical Sanger sequencing for genetic diagnostics, especially if various
diagnoses are considered.
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Background
Ganglioneuromatous polyposis (GP) is a very rare dis-
order, and it may be associated with various clinical
manifestations and syndromes such as Cowden syn-
drome, MEN II and NF1 [1–4]. The risk for malignant
transformation of ganglioneuromas is unknown, and the
combination of GP with colon cancer has been only sel-
dom reported.
We report the case of a patient with GP, adenocarcin-
oma, adenomas and lipomas of the colon, multiple gas-
troduodenal lesions as well as generalised lipomatosis
and macrocephaly, which was investigated through ex-
tensive clinical and molecular diagnostics, reporting the
findings and reviewing the current literature.
Case report
Personal and family history
A 60-years old male caucasian patient was referred to
the Outpatient Clinic for Hereditary Gastrointestinal
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Tumors at the University Cancer Center (UCC) Dresden
after being diagnosed with polyposis coli. There was no per-
sonal history of malignancies, yet at the age of 33 a thyroid
resection because of struma nodosa with an incidental find-
ing of two microfollicular adenomas was performed. Retro-
spectively, he acknowledged having observed lipomas of
the arms and torso since the age of 20. A significant comor-
bidity with hypertension, ischemic heart disease (myocar-
dial infarction and coronary stents one year previously),
tachyarrhythmia and hyperlipoproteinemia was reported.
His only brother died at age 48 due to an anaplastic T-
cell lymphoma and his daughter died due to a lymph-
oma at age 30 (Fig. 1). No further family members in-




The physical examination revealed multiple soft, painless,
subcutaneous nodules on the torso and limbs, which had
progressively developed over the past decades. There were
multiple lipomas of various size (the largest measuring ap-
proximately 6 x 4 cm), on the torso, limbs and on the
basal joint of the left thumb (Fig. 2a–c). In addition, a
solid, subcutaneous tumor (2.5 x 2.0 cm in size) was palp-
able at the lower leg (Fig. 3). Acral keratosis or facial pap-
ules such as trichilemmomas as well as papillomatous
papules – typical manifestations of patients with a Cow-
den syndrome - were not observed. Apart from a mild
lingua plicate and penile lentigiosis with irregular, pigmen-
ted macules affecting the penile glans, no other mucosal
abnormalities, particularly no papillomatosis of oral mu-
cosa were seen. There was a mild gynecomastia. Further-
more, the examination of the skin revealed sporadic
verrucae seborrhoicae, melanocytic nevi and sporadic red-
colored, flat papules on the torso in terms of senile
hemangiomae. In addition, a macrocephaly (occipital
frontal circumference (OFC) 64 cm (5 cm > 97.P) was
measured.
Endoscopy
A complete colonoscopy performed by the referring
physician revealed a macroscopically malignant tumor of
the descending colon near the splenic flexure, which in
the histological examination showed a high-grade intrae-
pithelial dysplasia as well as numerous polyps in the en-
tire colon and rectum, later confirmed by biopsies as
hyperplastic polyps and dysplastic adenomas (Fig. 4a–c).
Furthermore, the upper-GI endoscopy revealed more
than 60 gastric and about 25 duodenal polypoid lesions
(Fig. 5). Histological examination of the gastric lesions
had revealed distinctly regeneratory foveolar hyperplasia.
Radiological and nuclear imaging
The abdominal ultrasonography detected small ambigu-
ous hepatic lesions which were suggestive of liver metasta-
ses and haemangiomas, which were also observed in the
abdominal CT- and MRI-scans. No pathologic findings in
Fig. 1 Pedigree. The index patient is indicated by the black arrow
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other organs were seen. F-FDG PET-CT scan revealed a
focal accumulation of radio-nucleotide in the left-sided
upper abdomen, corresponding to the colonic tumor of
the splenic flexure, and a parajugular enhancement corre-
sponding to the left lobe of the thyroid gland; no evidence
of any metastases of the colonic cancer was found (images
not shown).
Surgical treatment
With the work-diagnosis of an attenuated adenomatous
polyposis coli or similarly atypical polyposis syndrome
with a colon carcinoma in a 60-year old male, we recom-
mended a (restorative) proctocolectomy, which was de-
clined by the patient. Consequently, we opted for a total
colectomy and lymphadenectomy (according to onco-
logic guidelines) with terminal ileostomy (Hartmann`s
procedure) as the first step of the treatment. The final
decision concerning further procedures shall be made
depending on the postoperative tumor staging of the
colon carcinoma and the clinical course of the disease.
The patient tolerated the procedure rather well, and the
suspicion of liver metastases could not be confirmed
intraoperatively.
Histopathology and immunohistochemical examination
Gross examination of the colectomy specimen revealed
a 91-cm segment of colon with 3 cm of terminal ileum,
the ileocecal valve and the appendix included. Through-
out the colon (on the mucosa), there were more than 50
rounded-to-sessile polyps ranging from 0.3 to 0.5 cm in
diameter. Two polyps in the ascending colon measured
1.5 cm. In addition, there was a flat lesion measuring 2.3
x 2.2 cm located in the splenic flexure, which on cross
section had a whitish appearance.
Histologic examination of the tumor revealed a mod-
erately differentiated adenocarcinoma arising from a
tubular adenoma, which infiltrated the lamina muscu-
laris propria without invasion of the pericolonic adipose
tissue (Fig. 6a). The examination of 26 mesocolic lymph
nodes revealed no lymph node metastases, thus the stage
defined for the tumor was pT2 N0 (0/26) M0 L0 V0 G2
R0. Histologic examination of the polyps revealed a large
number of ganglions and spindle cells proliferating be-
tween glands, replacing the lamina propria. Immunohis-
tochemical staining for S-100 protein was performed
and showed strong reactivity in the spindle cell compo-
nent, confirming the diagnosis of GP (Fig. 7). Addition-
ally, there were two submucosal lipomas in the
ascending colon and five tubular adenomas with low-
grade dysplasia (Fig. 6b). The intestinal ganglioneuromas
were confined to the mucosa. There were more than 50
Fig. 2 Multiple lipomas of various sizes on the torso (a), limbs (b) and on the left thumb basal joint right (c)
Fig. 3 Solid, subcutaneous tumor (2.5 x 2.0 cm in size) at the
lower leg
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sessile polypoid lesions, suggesting the diagnosis of
ganglioneuromatous polyposis.
Further diagnostics, clinical course and follow-up
As a result of the GP diagnosis, we attempted to estab-
lish a link between the clinical and histological manifest-
ation and the phenotype of the patient with any of the
known syndromes in which ganglioneuromas/ganglio-
neuromatosis/GP and other intestinal polyps may occur,
such as Cowden syndrome, Multiple endocrine neoplasia
type IIb, Neurofibromatosis von Recklinghausen type I,
atypical familial adenomatous polyposis among others.
Therefore, in addition to the preoperative staging, the
following diagnostic procedures aiming at a differential
diagnosis were performed:
- Measurement of parathormone, calcitonin,
adrenalin and noradrenalin, which revealed no
abnormal values;
- Ultrasonography of the thyroid gland and
parathyroid glands, revealing a left-sided thyroid nodule
but no enlarged parathyroid glands, which appeared as
cold nodules in the scintigraphy. To rule out a malig-
nancy, a fine-needle biopsy of the thyroid nodule was
performed and was negative.
- MRI-scan of the brain revealing no intracranial
tumor, yet left-sided hemangioma of the frontoparietal
skull.
An overview of the clinical differential diagnostics is
shown in Table 1.
After extensive multidisciplinary postoperative coun-
selling the patient decided to keep his residual rectum
despite of the persistent multiple rectal ganglioneuro-
mas, and therefore, an ileo-rectostomy was performed.
We followed up the patient by sigmoidoscopy with
rebiopsies of the persistent rectal ganglioneuromas to
exclude malignant transformation, esophago-gastro-
duodenoscopy and sonography every 6 and 12 months,
respectively. After a follow up of 6 years, neither metas-
tases, nor recurrence nor new primary malignancies
were detected.
Molecular analyses
After genetic counselling and obtaining informed written
consent, molecular analyses were performed in order to
further differentiate the patient`s phenotype and to iden-
tify a potential underlying germline mutation. Previous
conventional genetic testing in 2010 revealed no germ-
line mutations in known hereditary cancer syndrome
genes that are associated with either polyposis or colon
cancer. Given that the patient fulfilled the diagnostic cri-
teria for Cowden Syndrome based on the National com-
prehensive Cancer Network (NCCN) 2010 criteria, and
that he was above the threshold in the clinical scoring
system proposed by Tan et al. [5], we performed firstly
the investigation for germline mutations in the PTEN
gene. All coding exons and the promotor region of
PTEN were sequenced by Sanger-Sequencing of DNA
extracted from peripheral blood lymphocytes, in which
no pathogenic mutations were detected. Small deletions
and duplications of PTEN were excluded using MLPA
Fig. 4 Preoperative colonoscopic views: tumor of the descending colon (a), polyps of sigmoid colon (b) and rectum (c)
Fig. 5 Preoperative gastroscopic view: gastric polypoid lesions
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(„Multiplex Ligation-dependent Probe Amplification“;
Company Kit P225-B2). However, Sanger sequencing of
DNA of paraffin-embedded tumor tissue of the colon
carcinoma revealed a heterozygous somatic mutation in
PTEN: NM_000314:c.388C > T; p.Arg130*, resulting in a
stop-codon. No mutation in PTEN was found in the
DNA of tissue of the ganglioneuroma. In addition, se-
quencing of all codons of additional genes potentially re-
lated to Cowden syndrome (SDHB, SDHC, SDHD, Akt1
and PIK3CA) revealed no mutations. No pathogenic mu-
tations could be found in the RET-protooncogene, caus-
ing MEN2 syndrome, and in APC, MUTHY, BMPR1A
and SMAD4 (sequencing and MLPA), responsible for
different polyposis syndromes. To exclude HNPCC, test-
ing for microsatellite instability and immunhistochemis-
try on tumor tissue was performed and revealed a
microsatellite stable (MSS) colon carcinoma with normal
expression of the mismatch repair proteins MLH1,
MSH2, MSH6 and PMS2 (data not shown). The NF1-
gene was not analyzed, because there were no clinical
signs for neurofibromatosis Type 1 (no freckling, no
café-au-lait-spots, no neurofibromas).
To exclude genome-wide small deletions and duplica-
tions, we performed a comparative genomic hybridization
(CGH) array analysis using an Agilent 400 k microarray,
which revealed no pathogenic deletions or duplications.
Karyotype analysis on cultivated lymphocytes showed a
normal male karyotype 46,XY.
Despite of the negative results of the previous molecular
analyses in the germline, we assumed a Cowden syndrome
based on the patient’s clinical signs and manifestations.
Since a somatic pathogenic heterozygous mutation was
found in the colon carcinoma, we speculate that this
might be the second hit in PTEN, while the first hit, prob-
ably the constitutional mutation, could not be found with
the previously used methods. Therefore, when next-
generation sequencing technique became available, we re-
peated the analysis on DNA from patient’s blood using the
Illumina TruSight Cancer Panel target enrichment proto-
col (Illumina Inc., San Diego, CA, USA) which covers
1737 exons of 94 cancer-relevant genes as recently de-
scribed [6]. We identified a heterozygous nonsense muta-
tion in exon 2 of PTEN, NM_000314:c.138C >A;
p.Tyr46*. The Sanger-Sequencing for PTEN Exon 2 was
repeated on DNA from patient’s blood, as well as from tis-
sue of the ganglioneuroma and the colon carcinoma and
this time the mutation NM_000314:c.138C >A was con-
firmed in all samples in a heterozygous state (Fig. 8). Re-
evaluation of the firstly performed Sanger-sequencing data
revealed a small second peak at position c.138 in DNA
from the ganglioneuroma and the colon carcinoma, but
not from the patient`s blood (Fig. 8).
Fig. 6 Adenocarcinoma of the descending colon (20x) (a) and tubular, low-grade dysplastic tubulo-villous colon adenoma with low grade
dysplasia (20x) (b)
Fig. 7 Ganglioneuroma in HE (4x) (a) and S 100 (20x) staining (b)
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Discussion
Molecular analyses
Considering the phenotype and the pathological find-
ings, the most likely clinical diagnosis in our patient was
Cowden syndrome. However, no pathogenic PTEN-mu-
tation was detected in the germline at initial diagnosis in
2010 using Sanger-Sequencing and MLPA, only later
when using next-generation sequencing and then con-
firmed using Sanger Sequencing. Based on our findings,
allele drop-out is the most likely explanation for the
false-negative result. Allele drop-out is a major concern
of diagnostic sequencing using primer-based enrichment
(such as used in Sanger-Sequencing), since one variant
within a primer is sufficient to cause drop-out [7]. Using
new target-enrichment methods and next-generation se-
quencing (NGS) strategies these false-negative results
can be avoided [8]. Moreover, the step-wise analyses
using Sanger-Sequencing of the multiple genes that ac-
count for differential diagnoses is time-consuming and
expensive. All genes analyzed in our case by Sanger-
Sequencing are also represented on the Illumina Tru-
SightCancer Panel and hence can be simultaneously
Table 1 Clinical differential diagnosis
Syndrome Pros Cons Conclusion






















polyposis coli (FAP) and other
polyposis syndromes
colorectal adenomas and adenocarcinoma,




Fig. 8 Molecular genetic analyses of PTEN on DNA from blood and tumor tissue from a ganglioneuroma and the colon carcinoma. Next-
generation sequencing revealed a stop mutation in PTEN, NM_000314(PTEN):c.138C > A;p.Tyr56* in the patient’s blood in a heterozygous state
indicated by the allele frequency of about 47.5 % (left). This mutation has not been seen in the first Sanger-Sequencing performed in 2010 (upper
left), but was confirmed by a second Sanger-Sequencing in 2014 (lower left, indicated by arrow). The ganglioneuroma (middle) and the colon
carcinoma (right) showed the mutation NM_000314:c.138C > A only as a small peak in the first Sanger-Sequencing, but in a heterozygous state in
the second Sanger-Sequencing, thus indicating allele drop-out in the first Sequencing. The colon carcinoma additionally showed a second
somatic mutation NM_000314(PTEN):c.388C > T;p.Arg130* indicating compound-heterozygous mutation of PTEN in the malignant tumor
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tested in a single analysis. In the future, this approach
will allow for diagnosing more patients correctly, espe-
cially in patients with atypical phenotypes. Therefore, it
cannot be excluded that other “unusual” cases in the lit-
erature without identified mutations in known genes
must be considered as false-negatives. In our opinion,
transition of Sanger-Sequencing to a target NGS based
test would not only increase the reliability of diagnosis
but would also cut the turn-around time and costs and
improve genetic diagnosis especially in cases with un-
usual disease manifestations and/or in cases with mul-
tiple differential diagnoses.
Clinical aspects
Shekitka et al. proposed to divide ganglioneuroma for-
mations into three groups: polypoid ganglioneuromas,
diffuse ganglioneuromatosis and GP [3]. GP is a very
rare disorder and may be associated with different syn-
dromes and other preconditions [1–4]. In addition, some
patients with a GP also develop adenomatous, other
hamartomatous or juvenile colon polyps [2, 9–15]. The
combination of GP with adenocarcinomas of the colon
has been reported in a few cases only [3, 12, 16–18]. Al-
though single ganglioneuromas are not unusual in pa-
tients with Cowden syndrome [10, 19–21], GP in
Cowden syndrome is a rarity [1, 10, 18, 19] and may re-
sult in delayed diagnosis in patients with Cowden syn-
drome [22].
Very similar to our case, a 41-year-old patient with
GP, colon adenomas and cutaneous lipomas was re-
ported by Chan et al. in 2006 [10], however genetic test-
ing was not performed. In 2013, Vinitsky et al. reported
a 25-year-old woman who as a teenager showed macro-
cephaly and multiple gastrointestinal lesions including
ganglioneuromas, hamartomas, lipomas, juvenile, and
hyperplastic polyps in association with extra-intestinal
tumors including a retroperitoneal lipoma, storiform
collagenoma, and a fibrolipomatous hamartoma. This
patient had not developed a malignant tumor yet. PTEN
mutation analysis identified a deletion in exon 2, con-
firming the diagnosis of Cowden syndrome [22]. In
addition, in 2012 Trufant et al. presented the case of a
42-year-old man with colonic ganglioneuromatous
polyps and an adjacent colonic adenoma giving rise to a
signet-ring adenocarcinoma with lymph node metastases
in the setting of Cowden syndrome due to a pathologic
nonsense mutation at the PTEN locus. Unfortunately,
the location of the mutation in PTEN was not given
[18].
Accordingly, the pertinent question is whether there is
a molecular basis for such an unusual phenotype of GP
in patients with Cowden syndrome. Supposedly, a germ-
line nonsense mutations (or mutations) in the first exons
of PTEN could be associated with a severe phenotype.
Marsh et al. found that in patients with Cowden syn-
drome, only 33 % of the mutations in PTEN were non-
sense mutations, while mutations in the first three exons
are rare [23]. Although genotype-phenotype analyses
were performed in this study, no data were presented
concerning the association with GP. However, deletion
of PTEN has been shown to be associated with ganglio-
neuromatosis in the mouse [24]. Our patient as well as
the two patients with genetically confirmed Cowden-
Syndrome combined with ganglioneuromatosis in the lit-
erature carried either nonsense mutations or a partial
deletion of PTEN.
Based on the mentioned phenotype and the reported
cases of a combination of GP with adenocarcinomas of
the colon [3, 12, 16–18], it is feasible that ganglioneura-
matous polyposis is a pre-malignant condition, an opin-
ion shared by other authors [12].
Finally, the key issue is which surveillance program
and what kind of prophylactic procedure should be rec-
ommended to a patient with GP. Kanter et al. recom-
mended a proctocolectomy because of the pre-malignant
condition [12]. However, it is well-known that in those
patients, particularly the elderly, the quality of life after
this procedure (even if performed as a restorative proc-
tocolectomy) is worse than in patients with a colectomy
and ileo-rectostomy. In our patient, we initially recom-
mended a (restorative) proctocolectomy, assuming that
an attenuated adenomatous polyposis coli or another
atypical polyposis syndrome with a colon carcinoma was
present. However, the patient refused this procedure.
Whether or not his decision will have consequences in
the future clinical course remains unclear, but at least in
the 6-year follow-up neither metastases, recurrence nor
new primary malignancies were detected in the surveil-
lance programm.
Conclusions
If GP with extracolonic manifestations is diagnosed,
Cowden syndrome should strongly be suspected and
ascertained by combined clinical and molecular diagnos-
tics. Based on our experience, we recommend the early
implementation of Panel NGS rather than classical
Sanger sequencing for the genetic diagnosis, especially if
various differential diagnoses are assumed. Because GP
could represent a pre-malignant condition, a prophylac-
tic surgical oncologic procedure should always be
considered.
Consent
The patient`s diagnosis, treatment, councelling and sur-
veillance was performed following the principles of med-
ical ethics. An ethics approval with by the ethics
committee was not required.
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Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for review
to the Editor-in-Chief of this journal upon request.
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